PT141

PT-141 peptide is the common search name for bremelanotide, a melanocortin receptor agonist medication approved in the United States for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder, or HSDD 1. This educational article explains how PT-141 is studied, what the evidence says about libido and sexual desire, and why approved use should be separated from online peptide therapy claims. It does not provide personal dosing, injection, or treatment advice.

Friendly reminder: All peptides come in a pure, lyophilized (freeze-dried) form. Bacteriostatic Water is required to reconstitute the peptide. We do sell Bacteriostatic water in our store.

Important Notice

PT141 is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.